India’s pharmaceutical industry is one of the industry leaders in 2024, researching and developing new solutions for the world’s critical health issues. This year mainly focused on redefining patient care with advanced approaches such as AI-driven...
Manmohan Singh, frequently referred to as a "reluctant king" in his initial term as prime minister, died on Thursday, December 26, at the age of 92. A gentle-spoken leader, Singh was India's prime minister from 2004 to 2014, positioning him among...
In the pharmaceutical industry, a revenue growth of 9-11 percent is expected for FY25 and FY26, supported by digital transformation, increased internet availability, and broader expansion in Tier-I and Tier-II cities. The top local brokerage has...
The Precision Medicine Software market is fueled by the rising occurrence of chronic illnesses, progress in genomics, and heightened consumer interest in tailored healthcare solutions. The increasing prevalence of cancer, heart diseases, and...
The expansion of the global pharmaceutical eCommerce market is fueled by the swift embrace of digital platforms within the healthcare sector, with projections indicating a compound annual growth rate (CAGR) of 14.4% from 2024 to 2034. The market...
Verismo Therapeutics and HLB Innovation will expedite the clinical advancement of SynKIR-110 and SynKIR-310 for patients with solid tumors and blood cancers, respectively, reinforcing the shared goal of Verismo and HLB Group to promote their...
In the financial year 2024, India's pharmaceutical exports totaled Rs 2.3 lakh crore, an increase from Rs 1.1 lakh crore in FY14. Pharma exports increased by 8.36% from Rs 17,750 crore in July 2023 to Rs 18,670 crore in July 2024. The government...
The medical device sector in India is recognized as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities, as...
India's pharmaceutical sector, ranked as the third largest in the world by volume, was valued at $50 billion in the fiscal year 2023-24, as per Union Minister of State for Chemicals and Fertilizers Anupriya Patel. The domestic consumption value of...
In an exclusive interview with India Pharma Outlook, JaideepGogtay, Global Chief Medical Officer at Cipla, discusses how pharmaceutical companies in India are adjusting their R&D strategies to address antimicrobial resistance (AMR). The discussion...
.jpg)
, CDSCO.jpg)